WA
The startup develops receptor cell therapy that targets cancer antigens within immune cells to activate their response against solid tumors. This approach overcomes the immune suppression present in the tumor microenvironment, offering a potential pathway to effective cancer treatment for healthcare providers.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops receptor cell therapy that targets cancer antigens within immune cells to activate their response against solid tumors. This approach overcomes the immune suppression present in the tumor microenvironment, offering a potential pathway to effective cancer treatment for healthcare providers.